Ascend offers the SARS-COV-2-Antibody Assays from Siemens.
The COVID-19 SARS-CoV-2 IgG assay provides a qualitative interpretation and a semi-quantitative index to monitor IgG antibody levels (immunity). Ensuring vaccine effectiveness will play a key role in protecting the vulnerable dialysis population. Using the SARS-CoV-2 IgG assay post-vaccination, clinicians can detect patient IgG antibody levels and assess relative changes over time.
Antibody Testing Provides Valuable Information
- Establish a baseline immune status.
- Track the duration of a dialysis patient’s immune response.
- Verify the effectiveness of vaccines.